✦ LIBER ✦

Paclitaxel + BEP (T-BEP) Regimen as Induction Chemotherapy in Poor Prognosis Patients With Nonseminomatous Germ Cell Tumors: A Phase II Study

✍ Scribed by A. Tryakin; M. Fedyanin; D. Kanagavel; I. Fainstein; J. Sergeev; B. Polockij; V. Matveev; T. Zakharova; A. Garin; S. Tjulandin

Book ID: 116953680
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 305 KB
Volume: 78
Category: Article
ISSN: 0090-4295
DOI: 10.1016/j.urology.2011.05.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Paclitaxel + BEP (T-BEP) Regimen as Indu

Paclitaxel + BEP (T-BEP) Regimen as Induction Chemotherapy in Poor Prognosis Patients With Nonseminomatous Germ Cell Tumors: A Phase II Study

✍ A. Tryakin; M. Fedyanin; D. Kanagavel; I. Fainstein; J. Sergeev; B. Polockij; V. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 305 KB

## Objectives: To evaluate paclitaxel, bleomycin, etoposide, and cisplatin (t-bep) in patients with poor-prognosis nonseminomatous germ cell tumor (nsgct). paclitaxel is an active treatment of nonseminomatous germ cell tumors. ## Methods: The present study was an open-label, single-center, phase

7142 POSTER Toxicity and Use of Granuloc

7142 POSTER Toxicity and Use of Granulocyte Colony-stimulating Factor Prophylaxis in a Randomized Phase II Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP in Poor Prognosis Germ Cell Tumours (MRC TE23, CRUK 05/014, ISRCTN53643604)

✍ Huddart, R.A.; Gabe, R.; Stenning, S.P.; Pollock, P.; White, J.D.; Cafferty, F.H 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB

A Phase II Trial of TIP (Paclitaxel, Ifo

A Phase II Trial of TIP (Paclitaxel, Ifosfamide and Cisplatin) Given as Second-Line (Post-BEP) Salvage Chemotherapy for Patients With Metastatic Germ Cell Cancer: A Medical Research Council Trial

✍ Mead, G.M.; Cullen, M.H.; Huddart, R.; Harper, P.; Rustin, G.J.S.; Cook, P.A.; S 📂 Article 📅 2006 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 36 KB

A phase II study of alternating dose-den

A phase II study of alternating dose-dense chemotherapy in patients with poor-prognosis disseminated non-seminomatous germ cell tumors (NSGCT): Final results

✍ Karim Fizazi; Kim-Anh Do; Xuemei Wang; Debrah M. Prow; Laury Finn; Christopher J 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 172 KB

4521 POSTER Sequential high dose chemoth

4521 POSTER Sequential high dose chemotherapy with paclitaxel and etoposide, carboplatin, melphalan and autologous stem cell support in patients with germ cell tumors; a phase II study

✍ Koumakis, G.; Tryfonopoulos, D.; Vassilomanolakis, M.; Barbounis, V.; Res, E.; D 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Weekly regimen of epirubicin and paclita

Weekly regimen of epirubicin and paclitaxel as second-line chemotherapy in patients with metastatic transitional cell carcinoma of urothelial tract: results of a phase II study

✍ Antonio Rozzi; Margherita Salerno; Francesca Bordin; Ferdinando De Marco; Stefan 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 316 KB